LATEST NEWS
Keeping an "Eye on Innovation" Through News & Analysis
After XLRS Gene Therapy Disappoints, AGTC Looks to ‘Transformative Year’
Since announcing disappointing clinical trial results for one of its lead ophthalmic gene therapy candidates and the termination of its collaboration agreement with Biogen, Applied ...
OIS Index Follows the Stock Market Lower in December
The OIS Index declined 11% in December, marking the fourth month in a row in which ophthalmic stocks lost value. For the month, the overall ...
Will Changes in the FDA’s 510(k) Process Be Good for Innovators?
Key players in the medical device industry, including one major player in ophthalmology, have issued mixed reviews in response to the Food and Drug Administration’s ...
Alcon Executives Lay Out a Road Map for after the Spin-off
With a management team experienced in healthcare and ophthalmology, and market trends like aging increasing the need for ophthalmic care and a rich pipeline of ...
Chasing Presbyopia Utopia: Four Innovators and Their Search for Ophthalmology’s ‘Holy Grail’
The numbers can be overwhelming: 1.8 billion people globally were living with presbyopia in 2015, 826 million of whom had near vision impairment because they ...
Market Rebounds in November; OIS Index Does Not
The OIS Index of ophthalmic stocks declined by 2.3% in November on the heels of a 17.7% decline in October, failing to participate in the ...
LATEST PODCASTS
Candid Conversations With Ophthalmology's Innovators & Business Leaders
TESTIMONIALS
Why People Attend OIS
STAY UP TO DATE WITH OIS
Get the Latest News, Podcasts and Videos.